tiprankstipranks
Advertisement
Advertisement
C Ray Therapeutics Targets Strategic Engagement at SNMMI 2026 in Radiopharmaceuticals
PremiumPrivate CompaniesC Ray Therapeutics Targets Strategic Engagement at SNMMI 2026 in Radiopharmaceuticals
15d ago
C Ray Therapeutics Secures FDA-Active Cu-64 DMF and Expands Global Radiopharma CRDMO Role
Premium
Private Companies
C Ray Therapeutics Secures FDA-Active Cu-64 DMF and Expands Global Radiopharma CRDMO Role
22d ago
C Ray Therapeutics Highlights FDA-Listed Cu-64 DMF and Radiopharmaceutical Platform
Premium
Private Companies
C Ray Therapeutics Highlights FDA-Listed Cu-64 DMF and Radiopharmaceutical Platform
26d ago
C Ray Therapeutics Showcases Radiopharma CRDMO Strength Ahead of ANZSNM2026
PremiumPrivate CompaniesC Ray Therapeutics Showcases Radiopharma CRDMO Strength Ahead of ANZSNM2026
29d ago
C Ray Therapeutics Highlights Radiopharma Capabilities Ahead of ANZSNM2026
Premium
Private Companies
C Ray Therapeutics Highlights Radiopharma Capabilities Ahead of ANZSNM2026
1M ago
C Ray Therapeutics Highlights Radiopharma CRDMO Capabilities and ANZSNM2026 Presence
Premium
Private Companies
C Ray Therapeutics Highlights Radiopharma CRDMO Capabilities and ANZSNM2026 Presence
1M ago
C Ray Therapeutics Forms Strategic Lu-177 Supply Partnership in China
PremiumPrivate CompaniesC Ray Therapeutics Forms Strategic Lu-177 Supply Partnership in China
2M ago
C Ray Therapeutics, SHINE Technologies Form Lu-177 Supply Partnership in China
Premium
Private Companies
C Ray Therapeutics, SHINE Technologies Form Lu-177 Supply Partnership in China
2M ago
C-Ray Therapeutics Secures Exclusive Lu-177 Supply Rights for Mainland China Through SHINE Deal
Premium
Private Companies
C-Ray Therapeutics Secures Exclusive Lu-177 Supply Rights for Mainland China Through SHINE Deal
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100